Shinichi Ichiyama
Yokohama City University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Shinichi Ichiyama.
British Journal of Dermatology | 1989
Norihisa Ishii; K. Matsui; Shinichi Ichiyama; Yasuhide Takahashi; Hiroshi Nakajima
A case of infantile digital fibromatosis (IDF) in a 3‐year‐old girl is reported. Two tumours were present on the left fourth toe and one over the lateral aspect of the left heel. Histological examination revealed that the tumour cells contained intracytoplasmic inclusion bodies, characteristic for this condition. The tumours showed spontaneous regression without therapy.
Journal of Dermatology | 1991
Tetsuo Nagatani; Gaijiro Iemoto; Kanata Miyakawa; Shinichi Ichiyama; Yasuhide Takahashi; Mitsuaki Uchiyama; Hiroshi Nakajima
Nucleolar organizer regions (NORs) are loops of ribosomal DNA seen in nuclei, which are demonstrable as black dots (AgNOR) in tissue sections by silver (Ag) colloid staining. The number of such AgNORs is correlated with cellular activity and is an indicator of the degree of malignancy. In this study, 76 melanocytic lesions were analyzed by AgNOR staining, and the clinical and histopathological characteristics of malignant melanoma and melanocytic nevi were considered. Although the AgNOR counts for melanocytic nevi were significantly different from those in malignant melanoma, an obvious overlap between them was detected. The number of AgNORs in melanocytic nevi per cell was usually 1 or 2. On the other hand, the number of AgNORs per malignant melanoma cell was variable. Morphologically, malignant melanoma cells often showed dispersal of AgNORs throughout the nucleus as well as multiple nucleoli containing clustered AgNORs, whereas melanocytic nevus cells tended to have a regular nucleolus with tightly clustered AgNORs. The correlation between AgNOR count and pathological staging was uncertain, but a slight correlation between AgNOR count and thickness of the primary lesion was obtained. However, the AgNOR count in malignant melanoma was not a prognostic factor for the disease. Therefore, the AgNOR method is difficult to use for differential diagnosis between benign pigmented lesions and malignant melanoma. Nonetheless, an AgNOR count of more than two per cell favors a diagnosis of malignant melanoma.
Journal of Dermatology | 1990
Tetsuo Nagatani; Toshiko Matsuzaki; Shutaku Kim; Naoko Baba; Junko Osawa; Asami Sugiyama; Hitoshi Komatsu; Shinichi Ichiyama; Yasuhide Takahashi; Hideaki Miyamoto; Hiroshi Nakajima; Nagayoshi Shimoda
Since August of 1988, we have treated seven CTCL patients with extracorporeal photochemotherapy, including two with tumor‐stage mycosis fungoides (MF) showing mucinous degeneration, two with plaque‐stage MF, and two with erythrodermatous MF. One was withdrawn just after the first trial. For each patient, the phenotypes of peripheral blood lymphocytes were analyzed by flow cytometry in terms of the percentages of OKT11, OKT3, OKT4, Leu9, OKT8, B1, Tac, OKT9, OKIal, Leu7, Leu3a/4B4, and Leu3a/2H4 cells. These parameters were compared with the clinical responses according to skin score. The two patients with tumors died, but the five patients without tumors did not. Three of the 6 patients responded to the treatment. Side effects that are often associated with standard chemotherapy, such as bone marrow suppression, gastrointestinal symptoms and hair loss, were not observed. One cardiovascular event (1 patient) occurred. No significant changes in T‐cell subsets were seen during the course of therapy. These preliminary data suggest that extracorporeal photochemotherapy may be effective for CTCL other than tumor‐stage MF.
International Archives of Allergy and Immunology | 1988
Norihisa Ishii; Shinichi Ichiyama; Takayo Ishii; Ichiro Aoki; Kenji Okuda; Hiroshi Nakajima
For determining the mechanism of genetic control of D- penicillamine free-base-specific delayed-type hypersensitivity (DTH) in mice, footpad swelling response was employed. Studies w
Journal of Dermatology | 1993
Norihisa Ishii; Shinichi Ichiyama; Hiroshi Nakajima; Akira Ito
We report a case of HIV infection with herpes simplex, syphilis, and condyloma acuminatum in a 66‐year‐old heterosexual man. The patient was an asymptomatic carrier (group II) of HIV infection. Herpes simplex on his penis was controlled by aciclovir. Secondary syphilis was treated with penicillin G, after which skin lesions disappeared. These four diseases were all sexually transmitted diseases (STD).
International Journal of Dermatology | 1993
Tetsuo Nagatani; Megumi Miyazawa; Toshiko Matsuzaki; Hiroki Hayakawa; Gaijiro Iemoto; Shutaku Kim; Shinichi Ichiyama; Shizuo Naito; Naoko Baba; Asami Sugiyama; Michiko Aihara; Hideaki Miyamoto; Hiroshi Nakajima; Kiyoshi Shimoyama
A 65‐year‐old man was seen at the Ushioda Hospital in Au‐gust 1989, because of a 1‐month history of a tumor on the scalp. The tumor was excised and the diagnosis was malig‐nant lymphoma. The patient was then referred to our de‐partment in September 1989. Several nut‐sized lymph nodes wvepa‐b and m‐fepa for 2 months. Since then, the patient has been free of disease up to the time of writing, July 1992, a period of 2.5 years.
Skin Cancer | 1999
Makoto Yoshinaka; Shinichi Ichiyama; Tetsuo Nagatani; Hiroshi Nakajima
A case of a 37-year-old man with papillary eccrine adenoma is reported. The lesion presented clinically as a slowly growing nodule on the malleolus lateralis of the right foot. Histopathologically, the tumor was composed of multiple dilated tubular structures lined by two or more layers of epithelial cells. In some of the tubules, the inner cell layer formed intraluminal papillary projections.Papillary eccrine adenoma is a rare benign sweat gland neoplasm. There is no consensus on the cellular origin of this tumor. But in this study, we performed immunohistochemical staining study by several monoclonal antibodies against cytokeratin antigens. We reveal that the portion of the two layers of this tumor may defferentiate towards the dermal eccrine duct, whereas, the portion of the papillary projections may defferetiate towards the eccrine secretory portion.
European Journal of Cancer | 1992
Tetsuo Nagatani; Shinichi Ichiyama; Kanata Miyakawa; Mitsuaki Uchiyama
The S-year survival of patients with stage III malignant melanoma excluding N2 treated with DAV plus IFN-B is better than that of patients treated with BCG plus DAV, picibanil (OK432) plus DAV, DAV alone or dacarbazine alone. The 5year survival of patients treated with IFN-P plus DAV or dacarbazine was 84%, whereas that of patients treated with BCG plus DAV or dacarbazine, and picibanil plus DAV or dacarbaxine was 58 and 56%, respectively.
Skin Cancer | 1991
Yasuhide Takahashi; Kanata Miyakawa; Tetsuo Nagatani; Kazuo Takahashi; Hiroshi Nakajima; Shinichi Ichiyama; Hideaki Miyamoto; Mitsuaki Uchiyama
横浜市立大学皮膚科における最近10年間の上皮系悪性腫瘍について統計的観察を行った。上皮系皮膚悪性腫瘍は合計403例 (光線角化症, 放射線角化症, 砒素角化症を除くと314例) で, 外来新患総数の約0.6% (同じく0.5%) であった。最近10年間に増減傾向はないが, 当科における前回10年間の統計と比較すると基底細胞上皮腫, 光線角化症, Paget病, 付属器系悪性腫瘍の増加がみられた。性別では, 有棘細胞癌, Paget病, 毛包脂腺系腫瘍は男性に多かった。年齢では有棘細胞癌, Paget病, 転移性皮膚腫瘍は60~70歳代, 基底細胞上皮腫, Bowen病は50~70歳代, 光線角化症は60~80歳代に多かった。有棘細胞癌では前回の10年間に比べ高齢化傾向がみられた。発生部位は有棘細胞癌, 基底細胞上皮腫, 光線角化症は顔面, Bowen病は下肢・体幹に多くみられた。死亡例は有棘細胞癌7例, Paget病2例, 皮膚付属器系悪性腫瘍2例, 転移性皮膚腫瘍8例であった。
Skin Cancer | 1990
Tetsuo Nagatani; Shinichi Ichiyama; Yasuhide Takahashi; Hiroshi Nakajima
1988年8月以来2名の腫瘤期, 2名の局面期病変, 2名の紅皮症型菌状息肉症 (MF) の合計6名の患者に対してExtracorporeal photochemotherapyを施行し, その効果と末梢血液所見の変化とを検討した。腫瘤期の2名は治療に反応せず増悪が認められた。残りの4名は生存しているが, 7クール以上の治療を行った3名は50%以上の皮疹の改善が認められた。重篤な副作用は認められなかった。赤血球数, 白血球数, 血小板数, 末梢血液中のリンパ球サブセットに関しては治療開始前後で有意差は認められなかった。また, 有効症例および無効症例で治療前のリンパ球サブセットを比較すると, 無効例ではCD3陽性リンパ球, CD4陽性リンパ球が有意に低下しており, CD4陽性CD45RA陽性リンパ球およびCD4/CD8比にも低下が認められた。このことより, extracorporeal photochemotherapyは腫瘤期を除く菌状息肉症でCD4陽性T細胞,CD4陽性CD45RA陽性リンパ球の減少の認められない症例に有効であると言えた。